跳至主要内容
临床试验/ACTRN12621001072808
ACTRN12621001072808尚未招募未知

Hyperoxygenated Fatty Acids (HOFAs): The impact of implementation and dissemination on facial pressure injuries from medical devices (HOFA-ID) in adult intensive care patients

eanne Hunt0 个研究点目标入组 500 人开始时间: 2021年8月13日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
16 Years 至 o limit(—)
性别
All

入选标准

  • All adult patients in Intensive Care with facial medical devices (CPAP, BiPAP, ETT, NGT, Nasal prongs, High-flow nasal prongs) as part of their current treatment are eligible to participate in the trial.

排除标准

  • Any patient who does not have a medical facial device implemented as part of their current treatment.
  • Patients with significant traumatic facial injuries, burns or facial surgery where Hyperoxygenated Fatty Acids are deemed contraindicated.
  • Patients who at the end-of-life, or are not expected to stay in the ICU for at least 24-hours.

研究者

发起方
eanne Hunt

相似试验